These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28854511)

  • 1. Neonatal complex arrhythmias possibly related to a TTN mutation.
    Evans WN; Acherman RJ; Law IH; Von Bergen NH; Samson RA; Restrepo H
    J Neonatal Perinatal Med; 2017; 10(3):343-346. PubMed ID: 28854511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECGs in the ED.
    Tanel RE
    Pediatr Emerg Care; 2008 Nov; 24(11):803-4. PubMed ID: 19018229
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrocardiography Series. What is the cause of the regular wide QRS complex tachycardia?
    Lim SL; Teo SG; Kireyev D; Poh KK
    Singapore Med J; 2011 Jun; 52(6):394-8; quiz 399. PubMed ID: 21731989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tachycardias: considerations in childhood in the 90s].
    Gutiérrez-Larraya F; Jabón A
    An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
    [No Abstract]   [Full Text] [Related]  

  • 5. Narrow-Complex Tachycardia in a Woman With a 20-Year History of Supraventricular Tachycardia.
    Naksuk N; Kancharla K; Madhavan M
    JAMA Intern Med; 2017 Nov; 177(11):1676-1678. PubMed ID: 28975216
    [No Abstract]   [Full Text] [Related]  

  • 6. Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy.
    Fenrich AL; Perry JC; Friedman RA
    J Am Coll Cardiol; 1995 Apr; 25(5):1195-8. PubMed ID: 7897134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tachycardia with wide QRS. Limitations of electrocardiographic criteria in patients treated with anti-arrhythmia agents].
    Le Davay M; Victor J; Dupuis JM; Merheb M; Tran P; Tadeï A
    Ann Cardiol Angeiol (Paris); 1994 May; 43(5):253-5. PubMed ID: 8074416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic effect of flecainide toxicity.
    Courand PY; Sibellas F; Ranc S; Mullier A; Kirkorian G; Bonnefoy E
    Cardiol J; 2013; 20(2):203-5. PubMed ID: 23558880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wide-complex tachycardias. The importance of identifying the mechanism.
    Janeira LF
    Postgrad Med; 1996 Sep; 100(3):259-62, 265-6, 269-72 passim. PubMed ID: 8795658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fetal supraventricular tachyarrhythmias refractory to initial therapy].
    Malvino E; Bruno MC; Gallo JP; Medrano JC; Ferrante D
    Medicina (B Aires); 2005; 65(2):138-42. PubMed ID: 16075808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Supraventricular extrasystole after cardioversion with amiodarone].
    Meinertz T
    Dtsch Med Wochenschr; 2012 Jul; 137(28-29):1475. PubMed ID: 22760409
    [No Abstract]   [Full Text] [Related]  

  • 12. Spontaneous resolution of ventricular tachycardia with right bundle branch block morphology: a case report.
    Bostan OM; Celiker A; Ozme S
    Turk J Pediatr; 2003; 45(2):170-3. PubMed ID: 12921310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of a borderline-broad complex tachycardia.
    Kao SL; Ooi S
    Eur J Emerg Med; 2006 Dec; 13(6):369-71. PubMed ID: 17091063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supraventricular tachycardia with hydrops in a 27-week premature baby.
    Abraham P
    Int J Clin Pract; 2001 Oct; 55(8):569-70. PubMed ID: 11695082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flecainide in patient with aggressive catecholaminergic polymorphic ventricular tachycardia due to novel RYR2 mutation.
    Wangüemert-Pérez F; Ruiz-Hernández PM; Campuzano O; Caballero-Dorta E; Bosch C; Brugada J; Brugada R
    Minerva Cardioangiol; 2014 Aug; 62(4):363-6. PubMed ID: 25012103
    [No Abstract]   [Full Text] [Related]  

  • 16. [Flecaine: drug of choice for supraventricular tachycardias with anasarca. A case report].
    Hamel P; Febbraro W; Barjot P; Lindet Y; Muller G; Iselin M
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(1):37-9. PubMed ID: 9091542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
    Khoury A; Marai I; Suleiman M; Blich M; Lorber A; Gepstein L; Boulos M
    Heart Rhythm; 2013 Nov; 10(11):1671-5. PubMed ID: 23954267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology].
    Azancot-Benisty A; Areias JC; Oberhänsli I; Schmidt KG; Tulzer G; Viart P
    Arch Mal Coeur Vaiss; 1997 May; 90(5):735-43. PubMed ID: 9295960
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy in supraventricular arrhythmia].
    Follath F; Candinas R; Meyer B
    Schweiz Rundsch Med Prax; 1992 Apr; 81(18):579-81. PubMed ID: 1594845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of old and new electrocardiography criteria for differential diagnosis between ventricular tachycardia and supraventricular tachycardia with bundle branch block].
    Grimm W; Menz V; Hoffmann J; Maisch B
    Z Kardiol; 1996 Dec; 85(12):932-42. PubMed ID: 9082671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.